home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Copy Number Variation Linked to Neuroblastoma

 
  June, 19 2009 7:46
your information resource in human molecular genetics
 
     

The presence of a particular DNA copy number variant (CNV) may be associated with the development of an aggressive, often fatal type of childhood cancer of the sympathetic nervous system, a Nature paper suggests.

CNVs, changes in the copy number of specific DNA segments, stand alongside the better known single nucleotide polymorphisms (SNPs) as significant sources of genetic diversity. However, whereas certain SNPs have been found to contribute to cancer susceptibility, the role of CNVs remains less clear.

Here, John Maris and colleagues performed a genome-wide association study in patients with neuroblastoma - a cancer of the sympathetic nerve cells that control our fight or flight response and most commonly affects young children. They find that a common, heritable CNV found on chromosome 1 is frequently associated with the disease. The team highlights the presence of a previously unknown neuroblastoma-related gene within the CNV that is preferentially expressed in fetal brain and sympathetic nerve tissues. It's thought that this gene may be implicated in the early stages of tumour development.

CONTACT

John Maris (The Children's Hospital of Philadelphia and The University of Pennsylvania School of Medicine, Philadelphia, PA, USA)
E-mail: maris@chop.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.